Clinical Trials Browser

Recruiting × Interventional × Protons × Clear all

NCT04671667 2026-03-18

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Phase 2 Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT04946357 2026-03-10

EXTREM ION

Phase NA Recruiting

Sarcoma

NCT04083937 2026-03-09

PAROS

Phase NA Recruiting

Prostatic Neoplasms

NCT04278118 2026-02-17

HiPPI

Phase NA Recruiting

Brain Neoplasms, Meningioma, Neurilemmoma, Pituitary Neoplasms, Nerve Sheath Neoplasms

NCT04725903 2026-02-17

Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer

Phase NA Recruiting

Prostatic Neoplasms

NCT03180268 2026-01-14

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

Phase 3 Recruiting

Meningioma

NCT03801876 2026-01-14

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

Phase 3 Recruiting

Gastrointestinal

Clinical Stage I Esophageal Adenocarcinoma AJCC v8

NCT04656041 2025-11-14

Folfox+Irinotecan+Chemort In Esophageal Cancer

Phase 2 Recruiting

Gastrointestinal

Gastroesophageal Junction Adenocarcinoma

NCT06008730 2025-11-10

Proton Beam Radiation Therapy After Treatment for Resected N2 Non-Small Cell Lung Cancer

Phase 2 Recruiting

Resectable Lung Non-Small Cell Carcinoma

NCT04342429 2025-07-15

Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer

Phase NA Recruiting

Small Cell Lung Carcinoma

NCT04894643 2025-05-08

PARC

Phase NA Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT02824731 2024-12-16

Comparison of Proton and Photon Radiotherapy of Brain Tumors (ProtoChoice-Hirn)

Phase NA Recruiting

Brain Neoplasms

NCT05159193 2024-02-02

Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast Cancer

Phase 3 Recruiting

Breast Neoplasms

NCT05106699 2021-11-04

Carbon Ion Followed by Proton Radiotherapy for Prostate Cancer With Pelvic Lymph Nodes Metastases

Phase NA Recruiting

Prostatic Neoplasms